Clinical Trials Browser

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

Clinical Trials

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

DREAMM12

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

BRIDGE

POM Renal

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

Study of Copanlisib in Hepatic or Renal Impairment

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

RENAL

A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

JASINT1

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

TOP

Pharmacokinetics in Subjects With Renal Impairment

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Safinamide Renal Impairment Trial

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands